Real-World Outcomes of Brexucabtagene Autoleucel (brexu-cel) for Relapsed or Refractory (R/R) Adult B-Cell Acute Lymphoblastic Leukemia (B-cell ALL): Evidence from the CIBMTR Registry

Authors

Usama Gergis MD, MBA, Lehigh Valley Health NetworkFollow

Publication/Presentation Date

11-2023

Volume

142

Issue

1

Published In/Presented At

https://doi.org/10.1182/blood-2023-177693

Disciplines

Medicine and Health Sciences

Department(s)

Department of Medicine

Document Type

Article